An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study

Eldem, Bora; Lai, Timothy; Ngah, Nor; Vote, Brendan; Yu, Hyeong; Fabre, Alban; Backer, Arthur; Clunas, Nathan

doi:10.1007/s00417-017-3890-8

An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study

Copy For Citation

Eldem B., Lai T. Y. Y., Ngah N. F., Vote B., Yu H. G., Fabre A., ...More

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, vol.256, no.5, pp.963-973, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 256 Issue: 5
Publication Date: 2018
Doi Number: 10.1007/s00417-017-3890-8
Journal Name: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.963-973
Hacettepe University Affiliated: Yes

Abstract

To describe intravitreal ranibizumab treatment frequency, clinical monitoring, and visual outcomes (including mean central retinal thickness [CRT] and visual acuity [VA] changes from baseline) in neovascular age-related macular degeneration (nAMD) in real-world settings across three ranibizumab reimbursement scenarios in the Middle East, North Africa, and the Asia-Pacific region.